COVID-19 vaccine in India may be in one position until the end of the year, says the fitness minister

When will the COVID-19 vaccine be available in India? In reaction to this question, the Union Minister of Health and Family Welfare, Dr. Harsh Vardhan, said that a vaccine could be available until the end of this year.

“We are not falling behind anyone in the world in our efforts to contribute to the COVID vaccine matrix. In India, we have between 7 and 8 candidate vaccines, 3 of them in clinical trials and the rest in clinical trials and through later this year we hope to be able to get a vaccine against COVID,” he said.

Here are the main updates of the COVID-19 vaccine in India

Covaxin, the first coronavirus vaccine in India evolved through Bharat Biotech evolved through Bharat BioTech, the Indian Medical Research Council (ICMR) and the National Institute of Virology (NIV). The clinical trial to check the protection of the possible COVID-19 vaccine began in August.

“There were” no effects “in Covaxin’s Phase I trial, said Dr. E Venkata Rao, lead researcher of the trial at the Institute of Medical Sciences and Sum Hospital, Faculty of Medical Sciences.

ZyCoV-D, developed by Zydus Cadila began its phase II clinical trials from August 6. “The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, 2020, has been well tolerated,” Cadila Healthcare said.

“All subjects in the Phase I clinical trial were intensively monitored in a clinical pharmacology unit 24 hours after treatment for protection reasons and for 7 days thereafter, and the vaccine was found to be very safe,” said Zydus Cadila President Pankaj R Patel.

The Pune-based drug manufacturer, the Serum Institute of India, recently initiated a preclinical trial of a vaccine conducted through the University of Oxford. The vaccine manufacturer chose 17 sites nationwide for the trial. Approximately 1,600 other people between the ages of 18 and 25 will be enrolled in the clinical trial.

“Volunteers have no pain, fever, reaction to injection or systemic disease after vaccination,” said Dr. Jitendra Oswal, deputy director of Bharti Vidyapeeth Hospital and Medical College in Pune.

Click here to read Mint ePaperLivemint.com is now on Telegram.Join the Livemint channel on your telegram and updated

Log in to our to save your favorites. It’ll only take a moment.

Your query has expired, reconnect.

You are now subscribed to our newsletters. If you can’t find any of our emails, check your spam folder.

Leave a Comment

Your email address will not be published. Required fields are marked *